Skip to main content

Table 3 Association between participants’ demographics and the responses on the two global questions and the four factor scores of the revised Patients’ Attitudes Towards Deprescribing (rPATD)

From: Older people’s attitudes towards deprescribing cardiometabolic medication

 

Satisfaction with medicationa (n = 310)

Willingness to stopa (n = 310)

Burdenb (n = 309)

Appropriatenessb (n = 308)

Concerns about stoppingb (n = 306)

Involvementb (n = 308)

OR

p

OR

p

Coefficient

p

Coefficient

p

Coefficient

p

Coefficient

p

Age (years)

1.0

0.15

1.0

0.92

−0.005

0.50

−0.008

0.31

0.005

0.50

−0.005

0.48

Sex (male)

0.75

0.32

0.88

0.72

−0.007

0.80

−0.093

0.23

0.075

0.31

0.085

0.23

Number of medicines

(≤5)

0.61

0.12

0.87

0.72

0.018

0.35

0.098

0.22

0.074

0.34

0.040

0.58

(> 10)

0.61

0.36

0.41

0.002**

0.15

0.30

0.080

0.55

−0.047

0.72

Therapeutic area

0.76

0.40

0.71

0.41

−0.097

0.21

0.086

0.30

−0.022

0.78

0.071

0.35

Total model

 

0.15

 

0.16

 

0.004**

 

0.28

 

0.80

 

0.56

  1. aOrdinal logistic regression model
  2. bLinear regression model
  3. **Significant P-value after correcting for multiple testing (p = 0.0083): participants with more than 10 medicines scored higher on the burden factor
  4. - All 25 participant with > 10 medicines agreed with the statement, therefore no reliable estimation could be made
  5. Therapeutic area = Comparing patients using sulfonylurea and/or insulin (=0) and patient using a statin and at least one antihypertensive medication but no insulin or sulfonylurea (=1)